TAMPA, Fla. & STOCKHOLM--(BUSINESS WIRE)--Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) therapeutics, today announced that its ...
TAMPA, Fla. & DUBLIN--(BUSINESS WIRE)--Vycellix™, Inc., an immuno-discovery cell & gene therapy company, and Avectas Limited, a cell engineering technology business, today jointly announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback